Affluent Partners Holdings (MNNGF) Price & Analysis

Q: What was Affluent Partners Holdings Ltd’s price range in the past 12 months?

Affluent Partners Holdings Ltd lowest stock price was $0.04 and its highest was $0.08 in the past 12 months.

Q: What is Affluent Partners Holdings Ltd’s market cap?

Affluent Partners Holdings Ltd’s market cap is $64.36M.

Q: When is Affluent Partners Holdings Ltd’s upcoming earnings report date?

Affluent Partners Holdings Ltd’s upcoming earnings report date is Jul 01, 2026 which is in 116 days.

Q: How were Affluent Partners Holdings Ltd’s earnings last quarter?

Affluent Partners Holdings Ltd released its earnings results on Nov 28, 2025. The company reported <$0.001 earnings per share for the quarter, beating the consensus estimate of N/A by <$0.001.

Q: Is Affluent Partners Holdings Ltd overvalued?

According to Wall Street analysts Affluent Partners Holdings Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Q: Does Affluent Partners Holdings Ltd pay dividends?

Affluent Partners Holdings Ltd does not currently pay dividends.

Q: What is Affluent Partners Holdings Ltd’s EPS estimate?

Affluent Partners Holdings Ltd’s EPS estimate for its next earnings report is not yet available.

Q: How many shares outstanding does Affluent Partners Holdings Ltd have?

Affluent Partners Holdings Ltd has 932,254,100 shares outstanding.

Q: What happened to Affluent Partners Holdings Ltd’s price movement after its last earnings report?

Affluent Partners Holdings Ltd reported an EPS of <$0.001 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.

Q: Which hedge fund is a major shareholder of Affluent Partners Holdings Ltd?

Currently, no hedge funds are holding shares in MNNGF

Compare

0 Followers

MNNGF Stock Chart & Stats

$0.04

$0.00(0.00%)

At close: Jan 08 4:00 PM EST

$0.04

$0.00(0.00%)

Day’s Range― - ―

52-Week Range$0.05 - $0.08

Previous CloseN/A

Volume3.08K

Average Volume (3M)0.00

Market Cap

$64.36M

Enterprise Value$445.59M

Total Cash (Recent Filing)$57.46M

Total Debt (Recent Filing)$85.43M

Price to Earnings (P/E)49.8

Beta0.39

Next Earnings

Jul 01, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)<0.01

Shares Outstanding932,254,100

10 Day Avg. Volume0

30 Day Avg. Volume0

Financial Highlights & Ratios

PEG Ratio0.30

Price to Book (P/B)4.22

Price to Sales (P/S)7.57

P/FCF Ratio-61.23

Enterprise Value/Market Cap6.92

Enterprise Value/Revenue3.72

Enterprise Value/Gross Profit13.24

Enterprise Value/Ebitda42.55

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Diversified Business ModelA multi-sector model (real estate, advisory/AUM fees, and technology products) reduces single-market cyclicality and provides multiple, semi-independent cash engines. Over the medium term this diversification supports resilience, cross-selling and smoother revenue streams as individual segments fluctuate.

Strong Revenue Growth TrendSustained top-line growth at ~36% signals expanding customer adoption and project throughput. Durable revenue expansion can enable operating leverage and scale benefits, creating the opportunity to improve margins and fund reinvestment if cash conversion and cost structure are addressed over the coming quarters.

Manageable Leverage And Solid Equity BaseA debt-to-equity around 0.72 suggests leverage is moderate for a diversified asset holder, giving capacity to finance development or acquisitions without extreme refinancing risk. A stable equity base supports balance-sheet-backed real estate assets and provides room to pursue strategic investments if profitability and cash flow improve.

Bears Say

Negative Profitability MarginsPersistently negative EBIT and net margins indicate operational inefficiencies or unfavorable cost structure that prevent revenue from translating into shareholder returns. Without sustainable margin recovery, growth alone will not produce durable earnings or equity value accretion over the medium term.

Weak Cash GenerationNegative operating and free cash flows undermine the company’s ability to self-fund development, service debt, or return capital. Reliance on external financing or asset disposals raises execution risk and can constrain strategic flexibility until operations convert to consistent positive cash generation.

Negative Return On EquityA negative ROE shows the company is destroying shareholder capital rather than generating returns. Over months, this discourages equity funding and signals the need for either profit recovery or capital reallocation to improve return metrics and justify continued investor support.

Affluent Partners Holdings News

Baijin Life Science Adds Independent Director to Restore Governance Compliance

Affluent Partners Holdings ( ($HK:1466) ) has shared an update. Baijin Life Science Holdings has appointed Ms. Shen...

5d ago

Baijin Life Science Clarifies Board and Committee Roles in Governance Update

An announcement from Affluent Partners Holdings ( ($HK:1466) ) is now available. Baijin Life Science Holdings has released...

5d ago

Baijin Life Science Director Resigns, Triggering Temporary Governance Non-Compliance

Affluent Partners Holdings ( ($HK:1466) ) has issued an announcement. Baijin Life Science Holdings has announced the resignation...

1M ago

Baijin Life Science Sets Out Board and Committee Structure

Affluent Partners Holdings ( ($HK:1466) ) just unveiled an update. Baijin Life Science Holdings Limited has announced the...

1M ago

Baijin Life Science Enters Strategic Agreement with Guhuan Medical

Affluent Partners Holdings ( ($HK:1466) ) has shared an announcement. Baijin Life Science Holdings Limited has entered into...

3M ago

Baijin Life Science Completes HK$19.2 Million Share Issuance

Affluent Partners Holdings ( ($HK:1466) ) has issued an update. Baijin Life Science Holdings Limited has successfully completed...

3M ago

Baijin Life Science Holdings Reports Interim Profit Despite Revenue Decline

The latest update is out from Affluent Partners Holdings ( ($HK:1466) ). Baijin Life Science Holdings Limited announced...

3M ago

Baijin Life Science Holdings Issues Positive Profit Alert

Affluent Partners Holdings ( ($HK:1466) ) has provided an announcement. Baijin Life Science Holdings Limited, a company listed...

3M ago

Baijin Life Science Enters Strategic Partnership to Advance RNA Technology

Affluent Partners Holdings ( ($HK:1466) ) has provided an update. Baijin Life Science Holdings Limited, through its subsidiary...

4M ago

Baijin Life Science Holdings Reports Goodwill Impairment Amid Strategic Shift

Affluent Partners Holdings ( ($HK:1466) ) just unveiled an update. Baijin Life Science Holdings Limited, operating in the...

4M ago

MNNGF FAQ

What was Affluent Partners Holdings Ltd’s price range in the past 12 months?

Affluent Partners Holdings Ltd lowest stock price was $0.04 and its highest was $0.08 in the past 12 months.

What is Affluent Partners Holdings Ltd’s market cap?

Affluent Partners Holdings Ltd’s market cap is $64.36M.

When is Affluent Partners Holdings Ltd’s upcoming earnings report date?

Affluent Partners Holdings Ltd’s upcoming earnings report date is Jul 01, 2026 which is in 116 days.

How were Affluent Partners Holdings Ltd’s earnings last quarter?

Affluent Partners Holdings Ltd released its earnings results on Nov 28, 2025. The company reported <$0.001 earnings per share for the quarter, beating the consensus estimate of N/A by <$0.001.

Is Affluent Partners Holdings Ltd overvalued?

According to Wall Street analysts Affluent Partners Holdings Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Affluent Partners Holdings Ltd pay dividends?

Affluent Partners Holdings Ltd does not currently pay dividends.

What is Affluent Partners Holdings Ltd’s EPS estimate?

Affluent Partners Holdings Ltd’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Affluent Partners Holdings Ltd have?

Affluent Partners Holdings Ltd has 932,254,100 shares outstanding.

What happened to Affluent Partners Holdings Ltd’s price movement after its last earnings report?

Affluent Partners Holdings Ltd reported an EPS of <$0.001 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of Affluent Partners Holdings Ltd?

Currently, no hedge funds are holding shares in MNNGF

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Affluent Partners Holdings Ltd

Affluent Partners Holdings Limited, an investment holding company, engages in the purchase, process, design, production, assembly, trade, and wholesale distribution of pearls and jewelry products. It operates in two segments, Sales of Pearls and Jewellery Products, and Strategic Investment and Financial Services. The company is also involved in the real estate financial assets investment business. It has operations in Hong Kong, the United Kingdom, the United States, Japan, Europe, and the People's Republic of China. The company was formerly known as Man Sang Jewellery Holdings Limited and changed its name to Affluent Partners Holdings Limited in February 2017. Affluent Partners Holdings Limited was incorporated in 2014 and is based in Central, Hong Kong.